CheckMate 067: Phase 3 trial of nivolumab in melanoma | Dr Julie Vose at Annual Meeting 2015 - 101271

Spotlight
Video

CheckMate 067: Phase 3 trial of nivolumab in melanoma | Dr Julie Vose at Annual Meeting 2015

EMJ has 458 videos Subscribe Here

Loading........
Description: At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Julie M. Vose, MD, MBA, of the University of Nebraska Medical Center, Omaha, NE, discusses the phase 3 CheckMate 067 trial of nivolumab alone or combined with ipilimumab versus ipilimumab alone in treatment-naive patients with advanced melanoma.

–––

European Medical Journal

Website: http://emjreviews.com/...
Twitter: https://twitter.com/EMJRevi...
Facebook: https://www.facebook.com/em...
Shared By : EMJ
Posted on : 07/02/15
Added : 3 years ago



Recommended

Nothing found.

More From EMJ

Nothing found.